Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >
Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice
This item is licensed under:Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Title: | Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice |
Authors: | Deyama, Satoshi Browse this author | Shimoda, Kento Browse this author | Ikeda, Hiroyuki Browse this author | Fukuda, Hayato Browse this author | Shuto, Satoshi Browse this author →KAKEN DB | Minami, Masabumi Browse this author →KAKEN DB |
Keywords: | Antidepressant | omega-3 polyunsaturated fatty acid | Resolvin |
Issue Date: | Sep-2018 |
Publisher: | Japanese Pharmacological Society |
Journal Title: | Journal of pharmacological sciences |
Volume: | 138 |
Issue: | 1 |
Start Page: | 86 |
End Page: | 88 |
Publisher DOI: | 10.1016/j.jphs.2018.09.006 |
PMID: | 30293959 |
Abstract: | Eicosapentaenoic acid (EPA)-derived resolvin E1 (RvE1) and E2 (RvE2) have antidepressant effects. Here, we investigated the antidepressant effects of resolvin E3 (RvE3) in a mouse model of lipopolysaccharide (LPS)-induced depression. We observed that LPS (0.8 mg/kg, i.p.) significantly increased immobility time on the tail suspension test, and this depression-like behavior was dose-dependently attenuated by intracerebroventricular infusion of RvE3 (10 or 100 ng). No effects of LPS or intracerebroventricular infusion of RvE3 on locomotor activity were observed. These results indicate that RvE3, as well as RvE1 and RvE2, have antidepressant effects. (C) 2018 The Authors. Production and hosting by Elsevier B.V. |
Rights: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/72037 |
Appears in Collections: | 薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 南 雅文
|